1. Ghazawi FM, Cyr J, Darwich R, Le M, Rahme E, Moreau L, Netchiporouk E, Zubarev A, Roshdy O, Glassman SJ, Sasseville D, Litvinov IV. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study. J Am Acad Dermatol. 2019 Feb;80(2):448-459. PMID: 30092328.
2. Ghazawi FM, Le M, Alghazawi N, Rahme E, Moreau L, Netchiporouk E, Zubarev A, Roshdy O, Glassman SJ, Sasseville D, Litvinov IV. Trends in incidence of cutaneous malignant melanoma in Canada: 1992-2010 versus 2011-2015. J Am Acad Dermatol. 2019 Apr;80(4):1157-1159. PMID: 30395916
3. Ghazawi FM, Le M, Lagacé F, Cyr J, Alghazawi N, Zubarev A, Roy SF, Rahme E, Netchiporouk E, Roshdy O, Glassman SJ, Sasseville D, Litvinov IV. Incidence, Mortality, and Spatiotemporal Distribution of Cutaneous Malignant Melanoma Cases Across Canada. J Cutan Med Surg. 2019 Jul/Aug;23(4):394-412. PMID: 31132871
4. Ghazawi FM, Lim M, Dutz JP, Kirchhof MG. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration. Int J Dermatol. 2020 Sep;59(9):1043-1056. PMID: 32621284
5. Ghazawi FM, Netchiporouk E, Rahme E, Tsang M, Moreau L, Glassman S, Provost N, Gilbert M, Jean SE, Pehr K, Sasseville D, Litvinov IV. Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy. Cancer. 2017 Sep 15;123(18):3550-3567. PMID: 28493286
All Other Publications
ResearchGate
